AzTrials
AzTrials

Sleep Apnea, ObstructivesNCT07744854

Development of a Torso Patch Sensor (C-TraQ) as a Companion Device to a Fingertip Sensor (TipTraQ) for Direct Monitoring of Respiratory Effort

An observational study of Sleep Apnea, Obstructives and Sleep Apnea Central, run by PranaQ Pte. Ltd. at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The existing PranaQ system utilizes a fingertip sensor that captures PPG(Photoplethysmography) and accelerometer data, and its clinical validation is well-established. While PPG alone has shown effectiveness in diagnosing obstructive sleep apnea, its limited data channels restrict comprehensive evaluation. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
180 participants
Where
1 siteTaiwan
Study dates
5 Jun 2026to 23 Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patient who is scheduled for a sleep study.

Who may be able to join

  • Subjects must be 18 years of age or older.

Who cannot join

  • Opioids use
  • Chronic Obstructive Lung Disease, Global Initiative for Chronic Obstructive
  • Lung Disease (GOLD) categorization 3 or 4
  • Devastating strokes, with a modified Rankin score (mRS) ≥ 4
  • Interstitial lung disease

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ke Wei Chen, M.D. contact

+886-2-77415277

kwchen@pranaq.com

Taiwan1 site, 1 recruiting
  • Taipei Veterans General Hospital

    Taipei, Taiwan, 201

    Chun-Hsien Tseng Sleep Technician, 886-2-2875-7564, cmd@vghtpe.gov.tw

    Recruiting

Other trials in Taiwan

About this study

Official title: Development and Validation of Chest Patch Sensor for Physiological Signal Measurement and Sleep Apnea Evaluation

The existing PranaQ system utilizes a fingertip sensor that captures PPG(Photoplethysmography) and accelerometer data, and its clinical validation is well-established. While PPG alone has shown effectiveness in diagnosing obstructive sleep apnea, its limited data channels restrict comprehensive evaluation. For instance, it struggles to link apnea events with body position or differentiate between central and obstructive sleep apnea.

To address these limitations, the PranaQ system incorporates new sensors, specifically the chest patch sensor, to monitor respiratory movements via accelerometer signals. The additional respiration signal has the potential to improve diagnostic accuracy for apnea through additional information from respiratory effort.

Read the detailed description

Disease Background Sleep apnea-hypopnea syndrome (SAHS) represents a pervasive and significant public health challenge, affecting a substantial segment of the adult population. Epidemiological data indicate that 34% of men and 17% of women between the ages of 30 and 70 are impacted by this condition. Despite its high prevalence, SAHS remains vastly underdiagnosed and consequently undertreated, leaving a large portion of the affected population vulnerable to its associated health risks.

The established gold standard for the definitive diagnosis of sleep apnea is full-channel polysomnography (PSG). This comprehensive diagnostic procedure necessitates the simultaneous recording of a multitude of physiological and biological signals throughout the night, including electroencephalography (EEG) to monitor brain activity and sleep stages, electrooculography (EOG) for eye movements, electromyography (EMG) for muscle activity, and dedicated sensors for airflow, respiratory effort, and blood oxygen saturation.

However, the clinical utility and accessibility of PSG are severely constrained by several inherent limitations. The study is highly uncomfortable, requiring patients to be affixed with a complex array of over 20 sensors and leads. Crucially, PSG is exclusively a hospital-based procedure, confining patients to an unfamiliar environment which can itself negatively impact natural sleep patterns (the "first-night effect"). Furthermore, the subsequent analysis of the multichannel PSG data is resource-intensive, demanding hours of expert technician time for the meticulous labeling and scoring of individual sleep breathing events, which contributes to its high cost, significant time commitment, and impracticality for widespread population screening or routine follow-up evaluation. These barriers highlight the urgent need for more accessible, less burdensome, and cost-effective diagnostic alternatives for sleep apnea.

Description of PranaQ system

The PranaQ system integrates multiple wearable sensors-one for the fingertip and one for the chest-with a mobile application and an interpretable AI platform. The sensors collect the following data:

  1. T-TraQ (Fingertip Sensor): Records Photoplethysmography (PPG), accelerometer, and temperature data from the fingertip.
  2. C-TraQ (Torso Patch Sensor): Also collects PPG, accelerometer, and temperature data. In this study, there are three sensors attached over sternum, abdomen and left subclavicle area.

The PranaQ system, composed of wearable devices and cloud computing, is designed for both home and clinical settings to aid in the evaluation and diagnosis of suspected adult sleep apnea patients, as well as for long-term monitoring. Its function includes recording, storing, and exporting physiological waveforms. After the patient completes the recording, the collected signal data will be sent to the cloud for automatic report generation. The final sleep report will then be sent back to the healthcare provider through a browser-based user interface (PranaQ Expert Panel).

Clinical Evaluation Objectives and Purpose

  1. Validate the respiration information generated by the C-TraQ (Chest Patch Sensor). The raw signal from the chest patch is accelerometer-based. The respiration rate and waveform generated from the chest patch signal will be compared for consistency with information concurrently obtained from the thorax and abdominal belt collected through the PSG.
  2. Validate the multi-sensor PranaQ system for the diagnosis of sleep apnea The TST, TRT, ODI, and AHI(both obstructive and central) generated by the PranaQ system will be compared with the results from PSG labeled by a technician.
Keywords
apnea, chest patch
Medical subject headings
Sleep Apnea Syndromes, Sleep Apnea, Central, Apnea

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Respiratory Rate

    PSG recording estimated respiratory rate as ground truth to compare with the C-TraQ-generated respiratory rate.

    Measured: one night

  2. Sleep Position

    Sleep Position measured by PSG as ground truth to compare with C-TraQ generated sleep position

    Measured: One night

  3. AHI

    Technician labeled AHI based on PSG signal to compare with PranaQ system's prediction.

    Measured: One night

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2026
  2. Study start5 Jun 2026
  3. Primary completion23 Mar 2027 (estimated)
  4. Study completion23 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07744854
Sponsor's protocol ID
C-TraQ developement
Status last verified
Jul 2026
First submitted
29 Jul 2026
Last updated
4 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep Apnea, Obstructives and Sleep Apnea Central, run by PranaQ Pte. Ltd. at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ke Wei Chen, M.D. (+886-2-77415277, kwchen@pranaq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Respiratory Rate (time frame: one night). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in